NCT03636893View on ClinicalTrials.gov

Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 24, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

May 8, 2025

Conditions
Gastric CancerChemotherapy Effect
Interventions
DRUG

FLOT Chemotherapy

5-FU+Leucovorin+Docetaxel+Oxaliplatin

DRUG

SOX Chemotherapy

Oxaliplatin+Tegafur gimeracil oteracil potassium capsule (TGO)

Trial Locations (1)

200025

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT03636893 - Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | Biotech Hunter | Biotech Hunter